It is intended for the prevention and treatment of ARVIs, influenza and other viral infections, including in sickly children and children with underlying morbidity. The drug can be prescribed for infants from 1 month of age and shows efficacy at the onset of first symptoms, during the advanced stage, a complicated course of illness, and when used for preventive purposes. ANAFERON FOR CHILDREN® restores depleted immune system and prevents further morbidity. It is effective in combination therapy for bacterial infections. The drug is characterized by excellent safety.